Varicella-zoster virus (VZV), an alphaherpesvirus, establishes lifelong latent infection in the neurons of >90% humans worldwide, reactivating in one-third to cause shingles, debilitating pain and stroke. How VZV maintains latency remains unclear. Here, using ultra-deep virusenriched RNA sequencing of latently infected human trigeminal ganglia (TG), we demonstrate the consistent expression of a spliced VZV mRNA, antisense to VZV open reading frame 61 (ORF61). The spliced VZV latency-associated transcript (VLT) is expressed in human TG neurons and encodes a protein with late kinetics in productively infected cells in vitro and in shingles skin lesions. Whereas multiple alternatively spliced VLT isoforms (VLT ly ) are expressed during lytic infection, a single unique VLT isoform, which specifically suppresses ORF61 gene expression in co-transfected cells, predominates in latently VZVinfected human TG. The discovery of VLT links VZV with the other better characterized human and animal neurotropic alphaherpesviruses and provides insights into VZV latency.
D uring primary infection, neurotropic alphaherpesviruses (αHVs) gain access to neurons in sensory, cranial and autonomic ganglia to establish a lifelong latent infection from which they can reactivate to cause debilitating disease 1 . For the best-studied αHVs, including herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), pseudorabies virus and bovine herpesvirus 1 (BHV-1), viral latency has been shown to be accompanied by the expression of a single or restricted set of latency-associated transcripts (LATs) [2] [3] [4] [5] [6] . These transcripts map antisense to the gene encoding the conserved multifunctional HSV infected cell protein 0 (ICP0), to which varicella-zoster virus (VZV) open reading frame 61 (ORF61) is homologous, which besides inhibiting intrinsic cellular antiviral responses is the major transcriptional transactivator of lytic viral genes required for reactivation of latent HSV [2] [3] [4] [5] [6] [7] [8] [9] [10] . While the function of the LATs remains uncertain (reviewed in ref. 11 ), there is mounting evidence from work on HSV-1, HSV-2 and BHV-1 that LATs induce generalized transcriptional and/or translational repression 12 , and several studies have shown that LAT-encoded miR-NAs (e.g., miR-H2, in HSV-1) or proteins (e.g., BHV-1 latencyrelated protein) target viral mRNAs including ICP0 [13] [14] [15] . The exception has been VZV, a human-restricted αHV and causative agent of varicella and herpes zoster, for which no latency transcript mapping antisense to its ICP0 homologue ORF61 has been described 1, [16] [17] [18] . While the absence of a canonical latency transcript in VZV may represent a fundamental difference in the evolution and biology of this virus, it is notable that a putative LAT, antisense to ORF61, has also been described for simian varicella virus (SVV), the varicellovirus most closely related to VZV. However, neither the transcript nor its function in SVV infection have been studied in detail 7, 8 .
Like other herpesviruses, lytic VZV infection is characterized by full viral gene expression occurring with temporally linked immediate-early (IE), early (E) and late (L) kinetics to generate infectious virus progeny 19, 20 . By contrast, VZV gene expression during latency remains poorly defined 16, 18, [21] [22] [23] . This is largely due to the lack of appropriate animal 24 and, until recently, in vitro 25, 26 models, which accurately mimic VZV pathogenesis [24] [25] [26] . VZV latency has been extensively studied in cadaveric human trigeminal ganglia (TG), a prominent anatomic site of both HSV-1 and VZV latency, yielding conflicting results as to which VZV transcripts and proteins are expressed 27 . Whereas viral protein detection by immunohistochemistry (IHC) can largely be attributed to non-specific binding of anti-VZV antibody preparations 23, 28 , the time interval between death and TG specimen processing (post-mortem interval, PMI) determines the number and quantity of VZV transcripts detected 16, 18, 22 . Using PCR primers targeting all canonical VZV genes, only the lytic gene ORF63 is occasionally detected in TGs with PMI < 9 h 18 , whereas multiple viral transcripts of different kinetic classes are detected in human TGs with PMI > 9 h 16, 18, 22 and also frequently in animal models 29, 30 .
Here we describe the identification of a VZV latency-associated transcript (VLT), consistently detected in VZV and HSV-1 coinfected human TG that lies antisense to ORF61. Although multiple alternatively spliced transcripts are present during productive infection, the unique VLT isoform that supresses ORF61 gene transcription in co-transfected cells predominates during latency. The discovery of VLT unifies the VZV latent viral transcription programme with that of other better-characterized human and animal neurotropic αHVs while removing longstanding barriers to understanding VZV latency.
Results

Exclusive detection of HSV-1 LAT and miRNAs in human TG.
We first validated our experimental approach by sequencing enriched and unenriched viral transcripts from lytically VZV-or HSV-1-infected human retinal pigmented epithelial (ARPE-19) cells to demonstrate detection of all currently annotated VZV and HSV-1 genes at high specificity and sensitivity (Figs. 1 and 2 and Supplementary Fig. 1 ). RNA-Seq of unenriched RNA libraries from two latently VZV and HSV-1 co-infected human TGs (donors 1 and 2, Supplementary Tables 1 and 2) , enriched for polyadenylated transcripts or ribosomal RNA-depleted total RNA ( Supplementary Fig. 2 ), confirmed the presence of the stable 1.5/ 2.0-kb LAT-derived introns, the hallmark of HSV-1 latency 6 . Enrichment for polyadenylated HSV-1 sequences in the same TGs and five additional dually latently infected TGs (donors 1-7, Supplementary Tables 1 and 2) revealed both LAT introns and the near-complete 8.3-kb full-length LAT transcript from which they derive but no other viral transcripts ( Fig. 1 and Supplementary Fig. 3 ). The latency-associated miRNAs (mir-H2, mir-H3, mir-H4, mir-H6, mir-H7 and mir-H14) 13 were also detected in three TGs (donors 1, 3 and 5) selected for and analysed by miRNA sequencing of unenriched RNA libraries ( Supplementary  Fig. 4 ). These data illustrate the high specificity and sensitivity of our target-enriched RNA-Seq methodology and clearly demonstrate that the HSV-1 latency transcriptome in human TG is limited to the LATs and encoded miRNAs.
Identification of a spliced VZV latency-associated transcript.
While no VZV transcripts could be identified in non-enriched TG RNA samples ( Supplementary Fig. 5 ), enrichment for VZV sequences in polyadenylated RNA revealed the presence of a novel 496-nucleotide multi-exon transcript located antisense to ORF61 in all the seven TGs analysed (donors 1-7; Fig. 2 , Supplementary Figs. 5 and 6 and Supplementary Tables 1 and 2) . Manual inspection of the VZV sequence read data, combined with de novo transcript reconstruction, revealed five distinct exons (Figs. 2 and 3), two of which encode cleavage factor Ibinding motifs (TGTA), while the most 3' exon contained a canonical polyadenylation signal site (AAUAAA) ( Fig. 3 ). We term this the VZV latency-associated transcript (VLT) and subsequently confirmed that VLT nucleotides 40-460 (spanning exons 1-5) are detected as a single transcript using cDNA obtained from the five TGs with the highest VLT expression ( Fig. 4a and Supplementary Table 1 ). Except for ORF63 transcripts detected in six of the seven TGs (donors 2-7), no other VZV transcripts ( Fig. 2b and Supplementary Fig. 6 ) or miRNAs were detected in human TGs.
Distinct VLT mRNA isoforms expressed during lytic infection. The VLT locus was also transcribed in lytically VZV-infected ARPE-19 and MeWo cells (Figs. 2b and 4c and Supplementary  Fig. 6 ), enabling rapid amplification of cDNA ends (RACE) to determine 5' and 3' transcript boundaries. Unlike the single VLT isoform detected in latently VZV-infected human TG (Figs. 2 and 4a, b), gene transcription from the VLT locus appears Table 1 ). a Circos plots of the HSV-1 genome [purple band; sense and antisense open reading frames (ORFs) indicated as blue and red blocks, respectively], the latency associated transcripts (LATs) indicated as green blocks, with internal tracks revealing the lytic (left) and latent (right) transcriptomes using unenriched (grey tracks) and HSV-1-enriched (black tracks) libraries. Lytic transcriptomes were profiled using HSV-1-infected ARPE-19 cells. Latent HSV-1 transcriptomes are profiled from seven TGs, with each track depicting a single specimen. Peaks facing outward from the centre indicate reads mapping to the sense strand, while peaks facing inward originate from the antisense strand. The y axis is scaled to maximum read depth per library in all cases. b Linear representation of the HSV-1 LAT genomic region (green blocks in a), with blue and yellow tracks depicting HSV-1-enriched mRNA-Seq reads originating from the sense and antisense strand, respectively. Unenriched mRNA-Seq tracks for ARPE-19 cells, and TGs 1 and 2, are superimposed and shown in light blue (sense) or yellow (antisense), with overlapping regions in medium-blue and orange, respectively. HSV-1 genome coordinates are shown the HSV-1 reference strain 17 (NC_001806.2); Previously described HSV-1 ORFs within this locus (red boxes), miRNAs (orange blocks), LAT-encoded ORFs (green blocks), LAT-encoded small RNAs (dark red blocks) and LAT (blue boxes) are scaled representatively. . Paired-end read data sets were generated with read lengths of 2 × 34 bp (ARPE-19) or 2 × 76 bp (TG1 and TG2) or 2 × 151 bp (TG3-TG7) extremely complex during lytic VZV infection of ARPE-19 and MeWo cells (Figs. 2b and 4c, respectively), with additional upstream exons or alternative splicing in exons 3 and 4. Reverse transcriptase-quantitative PCR (RT-qPCR) did not detect any of the three most abundant lytic VLT (hereafter VLT ly ) isoforms (each VLT ly isoform uses a different upstream exon) in latently VZV-infected TGs (Fig. 4d ). Neither additional upstream exons nor alternative splicing of exons 3 and/or 4 were evident in the RNA-Seq data of human TG-derived VZV RNA. Thus a single unique VLT isoform is selectively expressed in latently VZVinfected human TG with short PMI.
VZV latency is characterized by VLT and ORF63 expression. To confirm that VLT expression is a general feature of VZV latency, we analysed TG specimens from 18 individuals (donors 1-18; Supplementary Table 1 ) for the presence of VZV and HSV-1 DNA and transcripts by qPCR and RT-qPCR, respectively. Thirteen TG were co-infected with VZV and HSV-1, while the remaining TG contained only VZV (donors 10 and 12) or HSV-1 (donors 16-18), (Supplementary Table 1 ). Fourteen of the 15 (93%) VZV nucleic acid-positive (VZV POS ) TGs expressed VLT and 9 of the 15 (60%) VZV POS TGs co-expressed ORF63 mRNA at lower levels relative to VLT ( Fig. 4e , Supplementary Fig. 7a Supplementary Table 1 ). VLT levels correlated significantly with ORF63 transcript levels ( Fig. 4f and Supplementary Fig. 7b ) but not with VZV DNA load or PMI excluding the possibility of viral reactivation after death ( Supplementary Fig. 7c, d) 18 . Next, we investigated the expression and localization of VLT, and as a control, VZV ORF63 transcript, in latently VZV-infected TGs (n = 12) and two VZV naive human fetal dorsal root ganglia (DRG) by in situ hybridization (ISH). VLT and ORF63 transcripts were localized to both the neuronal nucleus and cytoplasm of distinct neurons in latently VZV-infected TG but not in uninfected DRG (Fig. 4g-j and Supplementary Fig. 8 ). Significantly more (p = 0.04; paired Student's t-test) TG neurons expressed VLT than ORF63 transcript ( Fig. 4g ). RNase but not DNase treatment abolished ORF63-and VLT-specific ISH staining ( Supplementary  Fig. 8 ), confirming detection of VZV transcripts and not viral genomic DNA. In agreement with previous studies, both RT-qPCR and ISH data (Supplementary Table 1 and Supplementary  Fig. 9 ) revealed a much higher abundance and prevalence of HSV-1 LAT compared to VLT and VZV ORF63 RNA in human TG specimens 31 .
VLT encodes a protein that is expressed in lytic infection. In silico translation of the VLT isoform expressed in human TG predicted a 136 amino acid protein (pVLT), with a start codon and polyadenylation site/stop codon in exons 2 and 5, respectively ( Fig. 3b ). A polyclonal pVLT-specific antibody generated against the first 19 N-terminal residues of pVLT ( Fig. 3c ) confirmed pVLT expression in VLT-transfected ARPE-19 cells (Fig. 5a ). In lytically VZV-infected ARPE-19 cells, pVLT is coexpressed by cells expressing ORF62 protein (IE62) and glycoprotein E but not by uninfected cells (Fig. 5b ). The kinetic class of VLT ly was determined by RT-qPCR in VZV-infected ARPE-19 cells cultured in the presence or absence of phosphonoformic acid (PFA), a broad-spectrum herpesvirus DNA polymerase inhibitor 32 . Whereas no effect on ORF61 (IE gene) and ORF29 (E gene) transcription was observed, ORF49 (leaky L gene) transcription was markedly reduced in PFA-treated VZV-infected cells ( Fig. 5c ). PFA blocked VLT ly expression completely ( Fig. 5c ), demonstrating that VLT ly transcription follows a true late kinetic pattern in vitro. Finally, shingles skin biopsies were assayed for the expression of VLT ly and pVLT. ISH revealed VLT ly expression throughout the affected epidermis and dermis surrounding skin vesicles ( Fig. 5d ), while IHC analyses of consecutive sections for VZV ORF63 protein (IE63) and pVLT indicated coexpression in the same skin areas but not in healthy control skin ( Fig. 5e and Supplementary Fig. 10 ). Neither pVLT-nor IE63-specific IHC signal was detected in latently VZV-infected human TG sections.
VLT represses ORF61 expression in co-transfected cells.
Because VLT is antisense to VZV gene ORF61, a major viral transactivator and αHV ICP0 homologue 33 , we tested whether VLT affects ORF61 expression. ARPE-19 cells were cotransfected with four plasmids, each containing a single coding VZV sequence (ORFs 61, 62 and 63 and the mature, spliced coding sequence of VLT) under the control of a chicken betaactin (for ORF61, ORF63 and VLT) or human cytomegalovirus promoter (for ORF62). VLT expression significantly reduced ORF61, but not ORF62 and ORF63 transcript levels, in cotransfected cells ( Fig. 6a and Supplementary Fig. 11 ). Western blot analysis confirmed that VLT diminishes IE61 but not IE62, IE63 and α-tubulin protein abundance in co-transfected cells (Fig. 6b ). Mutation of the pVLT start codon within exon 2 ( Fig. 3b ) from ATG to ATA resulted in loss of pVLT expression in transfected ARPE-19 cells ( Fig. 6b and Supplementary Fig. 12 ) but did not abolish the inhibitory effect of VLT on ORF61 transcription and protein (IE61) expression in co-transfected cells (Fig. 6b ). The data implicate VLT, but not pVLT, in the selective repression of VZV ORF61 gene expression.
Discussion
We have identified a unique spliced VZV transcript, VLT, which is consistently expressed in latently VZV-infected human TG neurons. The VLT locus, including splice donor/acceptor sites and pVLT coding sequence, is highly conserved between wildtype and vaccine strains of VZV ( Supplementary Table 4 ). A feature shared by well-characterized latency transcripts of other αHVs, notably HSV-1 and BHV-1, is their ability to encode repressive miRNAs 13, 14 . However, in keeping with previous analyses of human TG 34 , we found no evidence of miRNAs encoded within VLT or the wider viral transcriptome. In contrast to other αHVs, latent VZV also transcribes the lytic ORF63 gene in a subset of latently infected TGs, suggesting an additional role for this viral gene in latency or early reactivation. Using a highly sensitive enriched RNA-Seq method, we found no evidence for the expression of other VZV genes during latent infection. Nor did we find evidence that HSV-1 latency in human TG involves the expression of viral transcripts other than the 8.3 kb full-length and 1.5/2.0 kb spliced HSV-1 LATs and associated miRNAs. Unlike HSV-1 LAT, VLT encodes a protein (pVLT) whose expression was strictly dependent on de novo virus DNA replication (true late kinetics) in lytically VZV-infected cells in vitro and in shingles skin lesions but was undetectable by IHC during latency.
The functions of VLT during latency and the VLT ly isoforms expressed during lytic VZV infection remain to be elucidated. Deletion of VZV ORF61, which would disrupt VLT, does not affect establishment of quiescent neuronal infection in the cotton tailed rat 35 , while a SVV ORF61 deletion mutant, which would disrupt the putative SVV LAT, could still establish latency in its natural host 36 . We have shown that in co-transfected cells VLT specifically suppresses the expression of VZV ORF61, an αHV ICP0 homologue and a promiscuous transactivator of lytic viral promotors 37 . The recent development of tractable in vitro cell 25, 26 and human fetal DRG organotypic cultures 38, 39 of VZV latency and reactivation, although not completely representative of the latent TG state, also provides exciting opportunities to explore further VLT function 40 .
With the availability of effective vaccines, VZV disease is much reduced in those geographic regions where coverage is high [41] [42] [43] . However, naturally infected individuals and vaccine recipients still harbour latent virus (wild type and/or vaccine strains) that can reactivate to cause disease 44 . The identification of the VLT, 35 years after VZV latency in human sensory ganglia was first described 45 , provides a significant advance in ongoing efforts to investigate and understand the mechanisms by which VZV establishes, maintains and reactivates from latency.
Methods
Human clinical specimens. Human TG were obtained at 6:01 h ± 1:47 h (average ± SD) after death (Supplementary Table 1 ). The brain samples and/or bio samples were obtained from The Netherlands Brain Bank (NBB), Netherlands Institute for Neuroscience, Amsterdam (open access: www.brainbank.nl). All Material has been collected from donors for or from whom a written informed consent for a brain autopsy and the use of the material and clinical information for research purposes had been obtained by the NBB. All study procedures were performed in compliance with relevant Dutch laws and institutional guidelines, approved by the local ethical committee (VU University Medical Center, Amsterdam, project number 2009/148) and was performed in accordance with the ethical standards of the Declaration of Helsinki. Majority of TG donors had a neurologic disease history affecting the central nervous system (mainly Alzheimer's and Parkinson's disease) and cause of death was not related to herpesvirus infections. TG biopsies were either formalin-fixed and paraffin-embedded (FFPE) or snap-frozen in liquid nitrogen and stored at −80°C. Human fetal DRG were obtained from the Academic Medical Centre Amsterdam (the Netherlands) according to relevant Dutch laws and approved by the institutional ethical committee (Erasmus MC, Rotterdam, MEC-2017-009). FFPE punch biopsies of one healthy control subject and five herpes zoster skin lesions were obtained for diagnostic purposes. Zoster biopsies were confirmed VZV DNA positive by virus-specific real-time PCR (qPCR). According to the institutional 'Opt-Out' system (Erasmus MC, Rotterdam, the Netherlands), which is defined by the National 'Code of Good Conduct' [Dutch: Code Goed Gebruik, May 2011], the surplus human herpes zoster FFPE tissues were available for the current study.
Cells and viruses. Human retinal pigmented epithelium ARPE-19 cells [American
Type Culture Collection (ATCC) CRL-2302] were maintained in 1:1 Dulbecco's modified Eagle's medium (DMEM; Lonza or Nissui)-Ham's F12 (Lonza or Sigma-Aldrich) medium supplemented with 8% heat-inactivated foetal bovine serum (FBS; Lonza or Sigma-Aldrich) and 0.6 mg/mL L-sodium glutamate (Lonza or Nacalai). The human MeWo melanoma cell [ATCC HTB-65] was maintained in DMEM supplemented with 8% FBS and 0.6 mg/mL L-sodium glutamate. Culture of VZV pOka strain and isolation of cell-free virus have been described previously 46 . Low passage clinical isolates VZV EMC-1 and HSV-1 strain F (ATCC VR-733) were cultured on ARPE-19 cells as described [47] [48] [49] . All cell cultures and virus infections were performed in a humidified CO 2 incubator at 37°C.
Nucleic acid extraction from human TG. Approximately one-fifth of snap-frozen human TG was mechanically dispersed and used for DNA isolation, while fourfifths of the same specimen was used for RNA isolation. DNA extraction was performed using the QIAamp DNA Kit (Qiagen) according to the manufacturer's instructions. For RNA isolation, samples were homogenized in TRIzol (Invitrogen), mixed vigorously with 200 µL chloroform and centrifuged for 15 min at 12,000×g at 4°C. RNA was isolated from the aqueous phase using the RNeasy Mini Kit, including on-column DNase I treatment (Qiagen). DNA and RNA concentration and integrity were analysed using a Qubit Flourometer (ThermoFisher).
RNA extraction from lytic VZV and HSV-1 infections. ARPE-19 cells were infected with VZV strain EMC-1 by co-cultivation VZV-infected or uninfected cells at a 1:8 cell ratio and harvested in 1 mL TRIzol at 72 h post-infection (hpi). Alternatively, semi-confluent ARPE-19 cell layers (75 cm 2 flask) were infected with HSV-1 strain F at a multiplicity of infection of 1 and harvested in 1 mL TRIzol at 24 hpi. RNA isolated as described above was subjected to additional DNase treatment using the TURBO DNA-free Kit according to the manufacturer's instructions (Ambion). Fig. 3 The genomic locus encoding the VZV latency-associated transcript (VLT). a Schematic diagram showing the location and structure of the five VLT exons (blue blocks) and introns (blue lines) within the genomic region 101,000-106,000 (coordinates refer to VZV reference strain Dumas; NC_001348.1) (Supplementary Table 3 ). b The VLT mRNA sequence including the 5' untranslated region; start and stop codons are highlighted in red italic, while the cleavage factor I (CFI)-binding motifs are highlighted in green italic and the canonical polyadenylation signal site (AATAAA) is underlined. Location and boundaries of VLT exons are indicated by vertical black lines. c The fully translated VLT protein (pVLT), with the sequence of peptide (red) used to produce rabbit polyclonal anti-pVLT antibody polyadenylated mRNA (captured by oligo-dT beads, as described by the SureSelect XT protocol) or underwent rRNA-depletion using a NEBNext® rRNA Depletion Kit [Human/Mouse/Rat] (New England Biolabs) according to the manufacturer's instructions. Subsequent to either procedure, captured/remaining RNAs were transcribed to produce cDNA. Fragmentation, cDNA second-strand synthesis, end repair, A-tailing and adapter ligation were performed as described in the enrichment protocol. Hybridization was performed using a modified strategy 50,51 that incorporated custom-designed SureSelect RNA bait sets for both VZV and HSV-1 in the same reaction at reduced concentration (1:10). Bait sets for VZV (Supplementary Data 1) and HSV-1 (Supplementary Data 2) were designed at 12× tiling (i.e., each base position in the genome was covered by 12 distinct 120-mer bait sequences) using custom in-house scripts. Hybridization for 24 h at 65°C was followed by post-capture washing and optimized PCRbased library indexing (12 cycles for RNA obtained from lytically infected cultures, 18 cycles for RNA obtained from TGs). Libraries generated from VZVand HSV-1-infected ARPE-19 cells were multiplexed and sequenced using a 75 cycle V2 high-output kit. Subsequently, three TG were multiplexed sequenced using a 150 cycle V2 mid-output kit followed by a further four TG multiplexed and sequenced using a 300 cycle V2 high-output kit. The decision to use increasing read lengths was informed by the initial discovery of VLT and the desire to better characterize intron splicing.
RNA-
Transcriptome mapping and de novo transcript reconstruction. Sequence run data were de-multiplexed using bcl2fastq2 v2.17 under stringent conditions (--barcode mismatches 0) and yielded between~31,000,000 and 107,700,000 paired-end reads per sample. Individual sequence data sets were trimmed using the TrimGalore software (http://www.bioinformatics.babraham.ac.uk/projects/ Supplementary Table 1 ), synthesized in the presence (+) or absence (−) of reverse transcriptase. Sanger sequencing of all five purified PCR products yielded identical sequences corresponding to VLT (Fig. 3b ). b Integrative Genomics Viewer (IGV) screenshot showing representative RNA-Seq data from a single TG. Paired-end reads are shown as fragments mapped across the VLT locus. Grey boxes (exons) connected by black lines (introns) indicate individual read pairs with distinct read-pairs separated by white space. Each fragment spans between 2 and 5 exons and there was no evidence of additional upstream exons. c In lytically VZV-infected MeWo cells, Sanger sequencing of amplicons generated through rapid amplification of cDNA ends revealed multiple VLT ly isoforms, visualized using IGV. Sequencing of 29 clones identified the three most abundant VLT ly isoform groups (red boxes) A (35%), B (19%) and C (15%). Note that the specific VLT isoform observed in latently infected TG was not observed among VLT ly isoforms. d Quantification of ORF63 transcript and VLT isoforms in lytically VZVinfected ARPE-19 cells (red; n = 3) and latently VZV-infected TG (blue; n = 19 TG), using primers/probes spanning VLT splice junctions between exons 3→4, A→1, B→1 and C→1 ( Fig. 4c and Supplementary Table 5 To confirm that enrichment for viral nucleic acids did not bias relative levels of viral gene transcription, transcripts per million counts were generated using FeatureCounts (subread package 55, 56 ) and visualized using scatter plots. High correlation (R 2 0.9252-0.9678) between enriched and unenriched transcriptomes were observed for both HSV-1 (n = 2 biological replicates) and VZV (n = 1), as shown in Supplementary Fig. 1 .
For de novo transcript reconstruction, VZV-specific mapping read pairs for each TG were extracted from BAM files and converted to raw fastq format for input into Trinity 57 . Trinity enables transcript reconstruction and, while limited in this case by the scarcity of VZV reads, was able to merge overlapping reads to produce transcript isoforms that, when mapped to the VZV reference genome using BBmap, spanned the four major introns observed in the VLT.
MicroRNA sequencing (miRNASeq) and qPCR profiling. miRNASeq libraries were prepared from 1 µg of total RNA, isolated from human TG and lytically VZVand HSV-1-infected ARPE-19 cells using the NEBNext ® small RNA Library Prep Set for Illumina ® according to the manufacturer's instructions. Libraries underwent 75 bp single-end sequencing using an Illumina NextSeq prior to demultiplexing (as outlined above). Sequence reads were adaptor-trimmed using TrimGalore and size selected using BBduk (provided with BBmap) so that only sequence reads between 17 and 26 bases in length were retained. These were mapped against VZV strain Dumas and the HSV-1 strain 17 reference genomes as well as miRDB using ShortStack (--dicermin 18 --mincov 1 --mismatches 2 --foldsize 200). No putative VZV miRNAs could be detected in either latently infected TGs or lytically infected ARPE-19 cells. By contrast, canonical HSV-1 miRNAs could be detected in both latently infected TGs and lytically infected ARPE-19 cells at high abundance.
cDNA synthesis and qPCR. cDNA synthesis was performed as described 18 using 2.0-11.7 µg [6.7 µg ± 0.64 (average ± SEM)] of TG-derived total RNA or 5 µg of cell-culture-derived DNase-free RNA and Superscript III reverse transcriptase (Invitrogen) with oligo(dT)12-18 primers (Invitrogen). Taqman qPCR was performed in triplicate on DNA and cDNA using Taqman 2× PCR Universal Master Mix (Applied Biosystems) with primer/probe pairs specific for VZV ORF62, ORF63 and the VLT exon 2→3, 3→4, A→1, B→1 and C→1 junctions and HSV-1 DNA 58 and LAT, (all from Eurogentec), β-actin (Applied Biosystems) and the human single copy gene hydroxymethylbilane synthase ( Supplementary Table 5 ).
Commercially quantified VZV and HSV-1 DNA stocks (Advanced Biotechnologies) and plasmids encoding VZV DNA amplicons (ORF63 and VLT; described in 'Plasmid construction' section below) were used to standardize qPCR reactions and used as positive control in each qPCR. RT-qPCR data were presented as absolute transcript copy number per 100 ng RNA ( Fig. 4e and Supplementary Figs. 7a and  9a) , relative transcript levels defined as 2 −(Ct-value VZV gene−Ct-value β-actin) (Fig. 4d, f and Supplementary Figs. 7b−d and 11 ) and fold change in gene expression using the 2 −ΔΔCt method 59 in which transcript levels were normalized to β-actin and a reference sample ( Figs. 5c and 6a ). 18 primer in a 20 µL reaction using the Transcriptor High Fidelity cDNA Synthesis Kit (Roche Diagnostics). qPCR following a dissociation curve analysis was performed as described previously 25 using SYBR Select Master Mix in a StepOnePlus Real-time PCR system (Thermo Fisher Scientific). The primer sets for β-actin and VZV ORF61 and ORF49 genes were described previously 25 and primers for VZV ORF29 (ORF29F2381 and ORF29R2440) and VLT (VLTexon1F and VLTexon2R) are presented in Supplementary Table 5 .
Plasmid construction. The VLT coding sequence (102,468-104,818, excluding introns indicated in Supplementary Table 3 Generation of rabbit anti-pVLT and -IE63 antibodies. Anti-VLT protein (pVLT) antibody was generated by Sigma-Aldrich by immunizing a rabbit with a synthetic peptide encoding the first 19 amino acids of pVLT (MPRLLRDRIAGIPNRVRTY; Fig. 3c ). The antibody was purified using pVLT peptide-conjugated NHS (Nhydroxysuccinimide)-activated sepharose (GE Healthcare Life Sciences). For probing of ORF63 (NP_040185.1), an anti-IE63 antibody was also generated by Sigma-Aldrich by immunizing a rabbit with GST-IE63 protein as described for anti-IE61 antibody 62 . Briefly, GST-IE63 protein was expressed in and purified from E. coli BL21 transformed with pGEX-IE63, in which the entire DNA fragment except the first ATG (i.e., ORF63 nucleotide positions 4-837) was cloned into pGEX6P-1 bacterial expression vector (GE Healthcare). The anti-IE63 antibody was purified using GST-conjugated NHS-activated sepharose for depleting anti-GST antibody and GST-IE63-conjugated NHS-activated sepharose.
Immunofluorescent staining and confocal microscopy of cells. The following primary mouse monoclonal antibodies directed to the indicated proteins were used: VZV IE62 (1:100 dilution; generous gift from Dr. Jürgen Haas (University of Edinburgh, UK) and Dr. Stipan Jonjić (Faculty of Medicine, Rijeka, Croatia)) 63 , VZV glycoprotein E (1:200 dilution; MAB8612, Millipore) and DYKDDDDK tag (FLAG tag) (1:100 dilution; Clone 1E6, WAKO). Alexa Fluor 488-and Alexa Fluor 594-conjugated goat-anti-rabbit and -anti-mouse IgG (1:250 dilution; Thermo Fisher Scientific) were used as secondary polyclonal antibodies, respectively. Hoechst 33342 (Sigma-Aldrich) was used for nuclear staining. Confocal microscopic analysis were performed as previously described 62, 64 .
IHC and immunofluorescence on skin biopsies. Deparaffinized and rehydrated 5 µm FFPE sections of human herpes zoster skin lesions and healthy control skin were subjected to heat-induced antigen retrieval with citrate buffer (pH = 6.0), blocked and incubated with mouse anti-VZV IE63 (1:1500 dilution; kindly provided by Dr. Sadzot-Delvaux; Liege, Belgium) 65 , rabbit anti-pVLT (1:100 dilution) or isotype control antibodies overnight at 4°C. Sections were subsequently incubated with biotinylated secondary goat-anti-rabbit immunoglobulin (Ig) or goat-anti-mouse Ig and streptavidin-conjugated horseradish peroxidase (all from Dako) for 1 h at room temperature. Signal was visualized using 3amino-9-ethylcarbazole and counterstained with haematoxylin (Sigma-Aldrich). For immunofluorescent staining, Alexa Fluor 488-and Alexa Fluor 594conjugated goat-anti-mouse and goat-anti-rabbit antibodies (all 1:250 dilution) were used, and sections were mounted with Prolong Diamond antifade mounting medium with 4,6-diamidino-2-phenylindole. Confocal microscopic analysis was performed as described 64 .
Plasmid co-transfection, RT-qPCR and immunoblotting. Plasmid cotransfection was performed using PEImax (molecular weight 40,000) (Polysciences, Inc.). High potency linear polyethyleneimine was dissolved in water (1 mg/mL), adjusted to pH = 7 with NaOH, filtered through an 0.22 µm filter and stored in aliquots at −20°C until use. CAG.Empty, CAG.VLT-FLAG or CAG.
VLT(ATA)-FLAG (2 µg) with CAG.ORF61, pcDNA.ORF62 and CAG.ORF63 (1 µg) were diluted in knockout DMEM/F12 media (Thermo Fisher Scientific) (50 µL) and PEImax solution (6 µL) were diluted in knockout DMEM/F12 media (50 µL), then both diluent were mixed, left at room temperature for 10-15 min to form polyplexes and transfected into ARPE-19 cell (1 × 10 5 cells/well in an 12well plate). Culture medium was changed at 16 h post-transfection and cultured for another 48 h. Cells were harvested and aliquoted into two fractions. Total RNA extraction from one fraction of transfectants, cDNA synthesis and relative qPCR were performed as described in 'Determination of kinetic class of VZV transcripts' section using the FavorPrep Blood/Cultured Cell Total RNA Mini Kit (FAVORGEN BIOTECH) instead of NucleoSpin RNA. The primer sets for VZV ORF62 (ORF62F2016 and ORF62R2083) and VLT (VLTexon2F and VLTexon2R-2) are presented in Supplementary Table 5 . Immunoblotting was performed using a rabbit polyclonal antibody against VZV IE61 or IE63, mouse monoclonal antibodies against alpha-tubulin (B-5-1-2; Sigma-Aldrich) and VZV IE62 (clone 2-B; generous gift from Dr. Yasuyuki Gomi (Research Foundation for Microbial Diseases, Osaka University)) 66 or DYKDDDDK (FLAG) tag (WAKO) for pVLT detection as described previously 62 . Uncropped images of immunoblotting are shown in Supplementary Figure 13 .
Data availability. All sequencing runs were performed using an Illumina NextSeq 550 and all demultiplexed fastq data set are available via the European Nucleotide Archive under study accession number PRJEB23238. RACE-derived VLT ly sequences are available through Genbank under accession numbers MG191301-MG191319.
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